ABUS logo

Arbutus Biopharma (ABUS) Selling, General & Administrative Expenses

Annual SGA

$22.48 M
+$4.64 M+26.02%

December 31, 2023

Summary

Performance

1-Year Change

+26.02%

3-Year Change

+51.4%

5-Year Change

+40.45%

15-Year Change

+39.35%

ABUS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.35%
ABUS annual SGA is higher than 43.35% of companies in Healthcare sector

High & Low

All-time High

$39.44 M
ABUS annual SGA is currently -43.01% below its historical high of $39.44 million

3-Year Low

$17.14 M
ABUS annual SGA is currently +31.16% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABUS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
ABUS next annual earnings announcement is scheduled for Feb 28, 2025

OtherABUSexpensesmetrics:

Annual Total Expenses

$96.17 M
ABUS annual total expenses is $96.17 million

Annual Operating Expenses

$96.17 M
ABUS annual total operating expenses is $96.17 million

Annual Cost Of Goods Sold

-
ABUS annual cost of goods sold value is unknown

Annual Interest Expense

$459.00 K
ABUS annual interest expense is $459.00 thousand

Quarterly SGA

$4.54 M
-$3.01 M-39.88%

September 30, 2024

Summary

Performance

3-Month Change

-39.88%

1-Year Change

-14.59%

3-Year Change

+6.78%

5-Year Change

+6.78%

ABUS Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.04%
ABUS quarterly SGA is higher than 36.04% of companies in Healthcare sector

High & Low

All-time High

$23.77 M
ABUS quarterly SGA is currently -80.91% below its historical high of $23.77 million

3-Year Low

$3.49 M
ABUS quarterly SGA is currently +29.89% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABUS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
ABUS next earnings announcement is scheduled for Feb 28, 2025

OtherABUSexpensesmetrics:

Quarterly Total Expenses

$18.81 M
ABUS quarterly total expenses is $18.81 million

Quarterly Operating Expenses

$18.81 M
ABUS quarterly total operating expenses is $18.81 million

Quarterly Cost Of Goods Sold

-
ABUS quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$29.00 K
ABUS quarterly interest expense is $29.00 thousand

TTM SGA

-$5.22 B
-$76.70 M-1.49%

September 30, 2024

Summary

Performance

3-Month Change

-22029.01%

1-Year Change

-23574.44%

3-Year Change

-29367.37%

5-Year Change

-29367.37%

ABUS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.24%
ABUS TTM SGA is higher than 7.24% of companies in Healthcare sector

High & Low

All-time High

-$187.59 M

3-Year Low

-$5.22 B
ABUS TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABUS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
ABUS next earnings announcement is scheduled for Feb 28, 2025

OtherABUSexpensesmetrics:

Annual Total Expenses

$96.17 M
ABUS annual total expenses is $96.17 million

Annual Operating Expenses

$96.17 M
ABUS annual total operating expenses is $96.17 million

TTM Cost Of Goods Sold

-
ABUS TTM cost of goods sold value is unknown

TTM Interest Expense

$151.00 K
ABUS TTM interest expense is $151.00 thousand

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$22.48 M
ABUS annual SGA is $22.48 million

Annual Operating Expenses

$96.17 M
ABUS annual total operating expenses is $96.17 million

Annual Cost Of Goods Sold

-
ABUS annual cost of goods sold value is unknown

ABUS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.0%-14.6%-10000.0%
3 y3 years+51.4%+6.8%-10000.0%
5 y5 years+40.5%+6.8%-10000.0%

ABUS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+31.2%-39.9%+29.9%-18.6%at low
5 y5-yearat high+51.4%-39.9%+141.7%-44.9%at low
alltimeall time-43.0%+1589.2%-80.9%+1864.1%-2682.4%at low

Arbutus Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.54 M(-39.9%)
$22.50 M(-5.5%)
Jun 2024
-
$7.55 M(+42.1%)
$23.80 M(+7.0%)
Mar 2024
-
$5.31 M(+4.1%)
$22.23 M(-1.1%)
Dec 2023
$22.48 M(+26.0%)
$5.10 M(-12.7%)
$22.48 M(+3.9%)
Sep 2023
-
$5.84 M(-2.3%)
$21.62 M(+12.2%)
Jun 2023
-
$5.98 M(+7.7%)
$19.27 M(+4.2%)
Mar 2023
-
$5.55 M(+30.7%)
$18.49 M(+3.7%)
Dec 2022
$17.83 M(+4.1%)
$4.25 M(+21.6%)
$17.83 M(-1.9%)
Sep 2022
-
$3.49 M(-32.8%)
$18.18 M(-3.7%)
Jun 2022
-
$5.20 M(+6.3%)
$18.87 M(+4.0%)
Mar 2022
-
$4.89 M(+6.4%)
$18.15 M(+5.9%)
Dec 2021
$17.14 M(+15.4%)
$4.60 M(+9.9%)
$17.14 M(+5.8%)
Sep 2021
-
$4.18 M(-6.6%)
$16.20 M(+0.7%)
Jun 2021
-
$4.48 M(+15.5%)
$16.08 M(+6.0%)
Mar 2021
-
$3.88 M(+5.9%)
$15.17 M(+2.2%)
Dec 2020
$14.85 M(-16.3%)
$3.66 M(-9.9%)
$14.85 M(+13.7%)
Sep 2020
-
$4.07 M(+14.0%)
$13.06 M(+6.7%)
Jun 2020
-
$3.57 M(+0.4%)
$12.24 M(-27.4%)
Mar 2020
-
$3.55 M(+89.3%)
$16.87 M(-4.8%)
Dec 2019
$17.73 M(+10.8%)
$1.88 M(-42.2%)
$17.73 M(-18.6%)
Sep 2019
-
$3.25 M(-60.3%)
$21.78 M(+2.9%)
Jun 2019
-
$8.19 M(+85.6%)
$21.16 M(+26.4%)
Mar 2019
-
$4.41 M(-25.6%)
$16.75 M(+4.6%)
Dec 2018
$16.00 M(-0.8%)
$5.93 M(+125.3%)
$16.00 M(+17.5%)
Sep 2018
-
$2.63 M(-30.3%)
$13.62 M(-7.0%)
Jun 2018
-
$3.77 M(+2.9%)
$14.65 M(-5.3%)
Mar 2018
-
$3.67 M(+3.6%)
$15.47 M(-4.1%)
Dec 2017
$16.13 M(-59.1%)
$3.54 M(-3.2%)
$16.13 M(-6.9%)
Sep 2017
-
$3.66 M(-20.4%)
$17.32 M(-0.4%)
Jun 2017
-
$4.60 M(+6.3%)
$17.38 M(-52.4%)
Mar 2017
-
$4.33 M(-8.6%)
$36.55 M(-7.3%)
Dec 2016
$39.44 M(+49.2%)
$4.73 M(+27.2%)
$39.44 M(-8.4%)
Sep 2016
-
$3.72 M(-84.3%)
$43.06 M(-8.5%)
Jun 2016
-
$23.77 M(+229.2%)
$47.05 M(+52.0%)
Mar 2016
-
$7.22 M(-13.6%)
$30.94 M(+17.0%)
Dec 2015
$26.44 M(+204.5%)
$8.35 M(+8.4%)
$26.44 M(+24.9%)
Sep 2015
-
$7.71 M(+0.6%)
$21.17 M(+39.0%)
Jun 2015
-
$7.66 M(+182.1%)
$15.22 M(+62.8%)
Mar 2015
-
$2.72 M(-11.9%)
$9.35 M(+7.7%)
DateAnnualQuarterlyTTM
Dec 2014
$8.68 M(+56.6%)
$3.08 M(+74.7%)
$8.68 M(+2.8%)
Sep 2014
-
$1.76 M(-1.3%)
$8.45 M(+10.5%)
Jun 2014
-
$1.79 M(-12.8%)
$7.64 M(+14.0%)
Mar 2014
-
$2.05 M(-27.9%)
$6.70 M(+20.9%)
Dec 2013
$5.55 M(-79.4%)
$2.85 M(+196.4%)
$5.55 M(-76.7%)
Sep 2013
-
$960.00 K(+13.1%)
$23.76 M(-2.3%)
Jun 2013
-
$849.00 K(-4.9%)
$24.33 M(-5.9%)
Mar 2013
-
$893.00 K(-95.8%)
$25.84 M(-3.5%)
Dec 2012
$26.88 M(+320.9%)
$21.06 M(+1277.5%)
$26.78 M(+238.1%)
Sep 2012
-
$1.53 M(-35.3%)
$7.92 M(+4.8%)
Jun 2012
-
$2.36 M(+29.5%)
$7.55 M(+10.5%)
Mar 2012
-
$1.83 M(-17.0%)
$6.84 M(+3.6%)
Dec 2011
$6.39 M(+33.6%)
$2.20 M(+89.1%)
$6.60 M(+15.2%)
Sep 2011
-
$1.16 M(-29.3%)
$5.73 M(-4.5%)
Jun 2011
-
$1.65 M(+3.8%)
$6.00 M(+11.5%)
Mar 2011
-
$1.59 M(+19.1%)
$5.38 M(+12.8%)
Dec 2010
$4.78 M(+20.5%)
$1.33 M(-7.3%)
$4.77 M(+4.2%)
Sep 2010
-
$1.44 M(+40.1%)
$4.58 M(+14.1%)
Jun 2010
-
$1.03 M(+5.0%)
$4.01 M(+1.5%)
Mar 2010
-
$976.30 K(-14.3%)
$3.95 M(+5.5%)
Dec 2009
$3.97 M(+9.6%)
$1.14 M(+30.8%)
$3.74 M(+32.0%)
Sep 2009
-
$870.40 K(-9.7%)
$2.84 M(-5.7%)
Jun 2009
-
$964.30 K(+25.3%)
$3.01 M(-21.1%)
Mar 2009
-
$769.70 K(+233.2%)
$3.81 M(+2.9%)
Dec 2008
$3.62 M(-18.5%)
$231.00 K(-77.9%)
$3.71 M(-18.1%)
Sep 2008
-
$1.04 M(-41.1%)
$4.52 M(+5.4%)
Jun 2008
-
$1.77 M(+167.2%)
$4.29 M(+5.1%)
Mar 2008
-
$662.20 K(-37.0%)
$4.09 M(+19.3%)
Dec 2007
$4.44 M(+15.3%)
$1.05 M(+29.6%)
$3.42 M(+44.3%)
Sep 2007
-
$810.70 K(-48.1%)
$2.37 M(+51.9%)
Jun 2007
-
$1.56 M
$1.56 M
Dec 2006
$3.85 M(+1.8%)
-
-
Dec 2005
$3.78 M(-51.2%)
-
-
Dec 2004
$7.76 M(+14.3%)
-
-
Dec 2003
$6.78 M(+13.6%)
-
-
Dec 2002
$5.97 M(+101.6%)
-
-
Dec 2001
$2.96 M(+47.7%)
-
-
Dec 2000
$2.00 M(+27.9%)
-
-
Dec 1999
$1.57 M(+17.8%)
-
-
Dec 1998
$1.33 M
-
-

FAQ

  • What is Arbutus Biopharma annual SGA?
  • What is the all time high annual SGA for Arbutus Biopharma?
  • What is Arbutus Biopharma annual SGA year-on-year change?
  • What is Arbutus Biopharma quarterly SGA?
  • What is the all time high quarterly SGA for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly SGA year-on-year change?
  • What is Arbutus Biopharma TTM SGA?
  • What is the all time high TTM SGA for Arbutus Biopharma?
  • What is Arbutus Biopharma TTM SGA year-on-year change?

What is Arbutus Biopharma annual SGA?

The current annual SGA of ABUS is $22.48 M

What is the all time high annual SGA for Arbutus Biopharma?

Arbutus Biopharma all-time high annual SGA is $39.44 M

What is Arbutus Biopharma annual SGA year-on-year change?

Over the past year, ABUS annual SGA has changed by +$4.64 M (+26.02%)

What is Arbutus Biopharma quarterly SGA?

The current quarterly SGA of ABUS is $4.54 M

What is the all time high quarterly SGA for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly SGA is $23.77 M

What is Arbutus Biopharma quarterly SGA year-on-year change?

Over the past year, ABUS quarterly SGA has changed by -$775.00 K (-14.59%)

What is Arbutus Biopharma TTM SGA?

The current TTM SGA of ABUS is -$5.22 B

What is the all time high TTM SGA for Arbutus Biopharma?

Arbutus Biopharma all-time high TTM SGA is -$187.59 M

What is Arbutus Biopharma TTM SGA year-on-year change?

Over the past year, ABUS TTM SGA has changed by -$5.24 B (-23574.44%)